The Opioid Action plan is a pilot that officials at the Dublin, Ohio-based company said would bring front-line tools to first responders in Ohio, Kentucky, Tennessee and West Virginia, while increasing its investment in education.
Even as more approvals roll in and industry officials talk about how biosimilars will bring significant savings in the coming decade, there is a concern that regulatory and reimbursement hurdles could prevent the industry from realizing the full savings of the less-expensive alternative to biologics.
As the generics industry squares off against price deflation, manufacturers are looking for new product areas in need of lower-cost alternatives — and recent Food and Drug Administration efforts are helping with the discovery process.
Five companies are close to winning $75,000 from the 2017 HITLAB World Cup of Voice-Activated Technology in Diabetes presented by Novo Nordisk.
The Merck Foundation has selected eight organizations that will implement programs to build partnerships between the healthcare sectors and others, redesign healthcare systems to improve diabetes care delivery and improve health outcomes for patients with diabetes.
The acquisition of LDI Integrated Pharmacy Services marks Diplomat’s second PBM acquisition this month, having acquired National Pharmaceutical Services on Nov. 6.
The findings suggest that clinicians should pay extra attention to females when conducting sleep-related assessments.
The portraits of women from around the world have been individually painted by hand on tablet devices. They will be published online and via social media to engage members of the public.
According to the American Diabetes Association, diabetes is the leading cause of blindness. Over time, high blood sugar levels from diabetes lead to damage of the retina.
Although providing immunizations is still a relatively new service line for the pharmacy, it is one that has grown rapidly in just a few short years — influenza vaccinations administered at pharmacies increased by more than 500% over a six-year time period. Yet, overall adult immunization rates in the United States remained relatively stagnant.